Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2016
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic CancerDavid Balli, Andrew J Rech, Ben Z Stanger, et al.
Cancer Research|January 5, 2011
Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesisDavid Balli, Yufang Zhang, Jonathan Snyder, et al.
Cancer Immunology Research|January 18, 2018
Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human CancerAndrew J Rech, David Balli, Alejandro Mantero, et al.
Plos Genetics|April 10, 2020
Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathwayChinmayee Goda, David Balli, Markaisa Black, et al.
Plos Genetics|December 22, 2017
FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomasDavid Milewski, David Balli, Vladimir Ustiyan, et al.
The EMBO Journal|January 5, 2013
Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transitionDavid Balli, Vladimir Ustiyan, Yufang Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2025
LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized TrialAndrew J Armstrong, Hilary Dietz, David Balli, et al.
The Journal of Biological Chemistry|June 19, 2013
Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesisYuqi Cai, David Balli, Vladimir Ustiyan, et al.
Pageof 3